Tag:
CytoFab
Latest Headlines
Latest Headlines
AZ readies mid-stage CytoFab trial
AstraZeneca has confirmed plans to begin Phase II clinical trials of CytoFab for severe sepsis. That's good news for BTG, which acquired CytoFab when it merged with Protherics. "AstraZeneca's
Protherics confirms talks with potential buyers
Shares of the UK's Protherics surged more than 30 percent after the biotech announced that "a number of parties" have expressed an interest in buying the company. Rumors about a possible buyout had
